Skip to main content

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

Osteosarcoma Maintenance Therapy With OST31-164

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Osteosarcoma Maintenance Therapy With OST31-164

RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors

Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Noninvasive Monitoring of Uterine Electrical Activity and Fetal Heart Rate: A New External Monitoring Device

A Study of PRN1008 in Adult Patients With Immune Thrombocytopenia (ITP)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of PRN1008 in Adult Patients With Immune Thrombocytopenia (ITP)

Study of Sacituzumab Govitecan-hziy in Metastatic Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study of Sacituzumab Govitecan-hziy in Metastatic Solid Tumors

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 181
  • Page 182
  • Page 183
  • Page 184
  • Page 185
  • Page 186
  • Page 187
  • Page 188
  • Page 189
  • …
  • Next page Next
  • Last page Last
Subscribe to